Optional Non-CME Satellite Presentations

Upgrade to a Stronger Foundation for Your Adult Patients with IgA Nephropathy

Jessica Coleman, MD

Ballroom A/B

This program is developed and offered by Travere Therapeutics.

Complement-Driven Glomerulopathies: Diagnosis, Current Treatment Landscape, and Patient Journey of C3G and Primary IC-MPGN

Mohammed Javeed Ansari, MD, MRCP

Ballroom C

This program is developed and offered by Apellis Pharmaceuticals.

Non-CME Satellite/Product Theatre AVAILABLE.

Click here for more information.

Navigating IgA Nephropathy: Pathogenesis, the Role of APRIL and the 4-Hit Process, and a Patient Case Study

Andrew Bomback, MD, MPH

Ballroom A/B

This program is developed and offered by Otsuka Pharmaceuticals..

Guideline Considerations for Early Treatment of Lupus Nephritis

Irfan Agha, MD, MRCP (UK)

Ballroom C

This program is developed and offered by GlaxoSmithKline.

Treatment Options for Patients Experiencing High-Dose Methotrexate-Induced Acute Kidney Injury

Jaya Kala, MD

Six Continents Room

This program is developed and offered by SERB Pharmaceuticals.

Achieving and Sustaining Remission in Severe Active ANCA-Associated Vasculitis: GPA and MPA

Luis Alvarez, MD, PhD

Ballroom A/B

This program is developed and offered by Amgen.

Understanding VANRAFIA (atrasentan)

Srini Srinivas, MD

Ballroom C

This program is developed and offered by Novartis.